FDA.reportPublic FDA data

iScreen™

Primary DI
00817405023318
Brand
iScreen™
Company
Instant Technologies, Inc.
Model
ABTDOAW14701A
Catalog number
ABTDOAW14701A
Device description
4 PANEL CLIA WAIVED SQUARE CUPAMP1000, COC300, MET1000, OPI2000
Published
2022-11-09
Public version status
Update
Distribution status
In Commercial Distribution
MRI safety
Labeling does not contain MRI Safety Information
Rx
true
OTC
true
Single use
true

Contact Domains#

Product Codes#

Code, Name table
CodeName
NFTTest, Amphetamine, Over The Counter
NFYTest, Cocaine And Cocaine Metabolites, Over The Counter
NGGTest, Methamphetamine, Over The Counter
NGLTest, Opiates, Over The Counter

Product Code Classifications#

Code, Device, Specialty table
CodeDeviceSpecialtyClass
NFTTest, Amphetamine, Over The CounterClinical Toxicology2
NFYTest, Cocaine And Cocaine Metabolites, Over The CounterClinical Toxicology2
NGGTest, Methamphetamine, Over The CounterClinical Toxicology2
NGLTest, Opiates, Over The CounterClinical Toxicology2

Premarket Submissions#

Submission, Supplement table
SubmissionSupplement
K182701000

Premarket Details#

Submission, Supplement, Device table
SubmissionSupplementDeviceApplicantDecision dateProduct code
K182701000Wondfo T-Cup Multi-Drug Urine Test CupGuangzhou Wondfo Biotech Co., Ltd.2018-12-03NFT

Identifiers And Packaging#

Identifier, Type, Agency table
IdentifierTypeAgencyPackage quantityStatus
30817405023319PackageGS14In Commercial Distribution
00817405023318PrimaryGS10
10817405023315Unit of UseGS10

Alternate GTIN / UPC / EAN Codes

Source identifier, GTIN-14 normalized, UPC-A table
Source identifierGTIN-14 normalizedUPC-AEAN-13
3081740502331930817405023319
00817405023318008174050233188174050233180817405023318
1081740502331510817405023315

GMDN Terms#

Term, Definition table
TermDefinition
Multiple drugs of abuse IVD, kit, rapid ICT, clinicalA collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of multiple drugs of abuse in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing.

Storage And Handling#

Type, Low, High table
TypeLowHighCondition
Storage Environment Temperature4 Degrees Celsius30 Degrees Celsius

Contacts#

Phone, Email table
PhoneEmail
1-800-340-4029Qa.Portsmouth@abbott.com

Regulatory Flags#

DUNS number
019410187
Device count
25
Kit
true
Lot or batch
true
Expiration date on label
true

Other Devices From This Company#

Primary DI, Brand, Model table
Primary DIBrandModelCatalogPublished
00817405024025iCassetteABTDFYW11201AABTDFYW11201A2023-11-30
00817405021154UScreen®USSCup-10MUSSCup-10M2021-01-13
00817405021192UScreen®USSCupA-12CLIAUSSCUPA-12CLIA2021-01-13
00817405021222UScreen®USSCup-10MMO300USSCup-10MMO3002021-01-13
10817405021304iScreen™IS1 MET-DX2 IS1 MET-DX2 2020-08-21
10817405021311iScreen™IS12-DX2 IS12-DX2 2020-08-21
10817405021328iScreen™IS12BUP-DX2 IS12BUP-DX2 2020-08-21
10817405021373UScreen®USSCupA-11CLIALCUSSCupA-11CLIALC2021-05-25
00817405022229iScreen™ABTDUAW110704DABTDUAW110704D2022-06-16
00817405023240iScreen™ABTDUAW112701AABTDUAW112701A2022-11-09
00817405023257iScreen™ABTDUAW16701AABTDUAW16701A2022-11-09
00817405023264iScreen™ABTDUAW17701AABTDUAW17701A2022-11-09
00817405023271iScreen™ABTDUAW110701AABTDUAW110701A2022-11-09
00817405023288iScreen™ABTDUAW110702BABTDUAW110702B2022-11-09
00817405023295iScreen™ABTDUAW15701AABTDUAW15701A2022-11-09
00817405023301iScreen™ABTDUAW113701AABTDUAW113701A2023-02-10
00817405023325iScreen™ABTDUAW17702BABTDUAW17702B2022-11-09
00817405023332iScreen™ABTDOAW17701AABTDOAW17701A2022-11-09
00817405023349iScreen™ABTDUAW110703CABTDUAW110703C2022-11-09
00817405023356iScreen™ABTDUAW111701AABTDUAW111701A2022-11-09

Other Devices Sharing Product Codes#

Primary DI, Brand, Company table
Primary DIBrandCompanyProduct codePublished
00850076289706HYSEN Multiple Drugs Test CupHYSEN INC.NFY2026-07-20
00850076289706HYSEN Multiple Drugs Test CupHYSEN INC.NGL2026-07-20
00850076289706HYSEN Multiple Drugs Test CupHYSEN INC.NFT2026-07-20
00850076289713HYSEN Multiple Drugs Test CupHYSEN INC.NFT2026-07-20
00850076289713HYSEN Multiple Drugs Test CupHYSEN INC.NFY2026-07-20
00850076289713HYSEN Multiple Drugs Test CupHYSEN INC.NGG2026-07-20
00850076289713HYSEN Multiple Drugs Test CupHYSEN INC.NGL2026-07-20
G474M2105010mLife Rapid Drug TestMlife Diagnostics, LLCNGG2026-07-20
G474M2105010mLife Rapid Drug TestMlife Diagnostics, LLCNFT2026-07-20
G474M2105010mLife Rapid Drug TestMlife Diagnostics, LLCNFY2026-07-20
G474M2105010mLife Rapid Drug TestMlife Diagnostics, LLCNGL2026-07-20
G474M2107010mLife Rapid Drug TestMlife Diagnostics, LLCNGL2026-07-20
G474M2107010mLife Rapid Drug TestMlife Diagnostics, LLCNGG2026-07-20
G474M2107010mLife Rapid Drug TestMlife Diagnostics, LLCNFY2026-07-20
G474M2107010mLife Rapid Drug TestMlife Diagnostics, LLCNFT2026-07-20
G474M2113010mLife Rapid Drug TestMlife Diagnostics, LLCNGG2026-07-20
G474M2113010mLife Rapid Drug TestMlife Diagnostics, LLCNFT2026-07-20
G474M2113010mLife Rapid Drug TestMlife Diagnostics, LLCNFY2026-07-20
G474M2113010mLife Rapid Drug TestMlife Diagnostics, LLCNGL2026-07-20
G474M2116010mLife Rapid Drug TestMlife Diagnostics, LLCNGG2026-07-20
G474M2116010mLife Rapid Drug TestMlife Diagnostics, LLCNFY2026-07-20
G474M2116010mLife Rapid Drug TestMlife Diagnostics, LLCNGL2026-07-20
G474M2116010mLife Rapid Drug TestMlife Diagnostics, LLCNFT2026-07-20
G474M2117010mLife Rapid Drug TestMlife Diagnostics, LLCNFY2026-07-20
G474M2117010mLife Rapid Drug TestMlife Diagnostics, LLCNFT2026-07-20
G474M2117010mLife Rapid Drug TestMlife Diagnostics, LLCNGG2026-07-20
G474M2117010mLife Rapid Drug TestMlife Diagnostics, LLCNGL2026-07-20
10722066018009Rapid ResponseBTNX IncNGL2026-07-14
10722066018009Rapid ResponseBTNX IncNGG2026-07-14
10722066018009Rapid ResponseBTNX IncNFY2026-07-14